Which Emerging Trends Are Driving The COVID-19 Saliva Screening Test Potential Market Toward $6.03 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The COVID-19 Saliva Screening Test Potential Market?
The potential market capacity for the COVID-19 saliva screening test has experienced significant growth in the past few years. The market, which is anticipated to rise from $3.9 billion in 2024 to $4.28 billion in 2025, predicts a compound annual growth rate (CAGR) of 9.7%. The acceleration in growth during the historical phase can be traced back to the feasibility of home testing, an unparalleled demand for diagnostic screening, an increase in public awareness, and investment in research and development.
The potential market size for the covid-19 saliva screening test is set to experience robust growth in the impending years, reaching a value of $6.03 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. This growth during the forecast period could be due to the merging with screening programs, support from regulatory bodies, the growing need for quick, at-the-bedside COVID-19 tests, a rising population, and the surge of online shopping. Major trends predicted during this period include greater usage in non-medical sectors, collaboration with digital health platforms, the development of cutting-edge technologies, advances in technology, and strategic alliances.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp
Which Growth Drivers Are Shaping The COVID-19 Saliva Screening Test Potential Market Outlook?
The growth of the potential market for COVID-19 saliva screening tests is anticipated to be driven by rising healthcare spending. Healthcare spending encompasses the total outlay on healthcare-related products and services, including prescription medications, hospitalisation, consultations with doctors, medical devices, and public health initiatives. Factors contributing to the surge in healthcare spending include minimally invasive procedures, innovative diagnostic tools, increased research and development for novel drugs, the use of healthcare services, and specialty medications. This escalated spending in healthcare can equip with the needed resources and support to fully utilise COVID-19 saliva screening tests, resulting in more efficient management of the pandemic and improved public health results. As an example, the UK healthcare expenditure in 2022 was about $354.88 billion (£283 billion), as reported by the Office for National Statistics, a UK-based national statistics agency focusing on epilepsy. This marks a 0.7% nominal increase from the 2021 total spending. Therefore, it can be concluded that the expanded healthcare spending is stimulating the growth of the potential market for COVID-19 saliva screening tests.
What Are The Primary Segmentation Parameters In The COVID-19 Saliva Screening Test Potential Market?
The covid-19 saliva screening test potentialmarket covered in this report is segmented –
1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing; Decentralized Testing
Subsegments:
1) By Travel Stations: Airports; Train Stations; Bus Stations; Seaports
2) By Sports Arenas: Stadiums; Arenas; Event Halls
3) By Entertainment Venues: Theaters; Concert Halls; Amusement Parks; Nightclubs
4) By Corporate Campus Environments: Offices; Corporate Campuses; Business Parks
5) By Universities And Colleges: Higher Education Campuses; Research Institutions; Student Housing Areas
6) By Factories: Manufacturing Plants; Production Facilities; Industrial Sites
7) By Other Locations: Healthcare Facilities; Government Buildings; Public Transportation Hubs; Shopping Centers; Other Public Or Private Venues
How Are Market Trends Influencing Competition In The COVID-19 Saliva Screening Test Potential Market?
Leading businesses in the potential market for COVID-19 saliva screening tests are focusing their efforts on developing breakthrough technologies like data-sharing platforms. The goal is to improve real-time communication and collaboration between healthcare providers, labs, and national health departments, thus sharpening the effectiveness and precision of testing, tracking, and reaction efforts during this pandemic. Digital systems, like data-sharing platforms, facilitate the safe transmission of data between various parties, such as healthcare organizations, researchers, and other institutions. They encourage collaboration and access to information to enhance decision-making, efficacy, and outcomes across various sectors. For example, in May 2024, the US-based healthcare network Mount Sinai Health System established the Center for Healthcare Readiness. The Center is committed to refining strategies for public health emergency responses, ensuring that health systems adequately manage significant crises like epidemics or natural disasters. It’s purpose is to augment Mount Sinai Health System’s capabilities, and work together with local, regional, and national partners in creating thorough readiness plans.
Which Organizations Are At The Forefront Of The COVID-19 Saliva Screening Test Potential Market?
Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For COVID-19 Saliva Screening Test Potential Market Expansion?
North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16026&type=smp
Browse Through More Reports Similar to the Global COVID-19 Saliva Screening Test Potential Market 2025, By The Business Research Company
Drug Screening Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Security Screening Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report
Employment Screening Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
